Skip to main content
SpringerLink
Log in
Book cover

Evaluation and Management of Liver Masses pp 171–199Cite as

Rare Liver Tumors

  • Chapter
  • First Online:

  • 297 Accesses

Abstract

The appearance of a mass in the hepatic parenchyma may signal the presence of a myriad of systemic and focal pathological processes. Many of the more common focal liver lesions are described elsewhere in this book. The aim of this chapter is to describe imaging and pathologic findings of some of the more uncommon masses which can arise in the liver and their management. The rare adult and pediatric liver masses can mimic the more commonly encountered liver masses clinically as well as radiologically. A brief review of the literature regarding their presentation, current diagnostic approach, and treatment is presented.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Newman KD. Malignant liver tumors of children. Semin Pediatr Surg. 1992;1(2):145–51.

    CAS  PubMed  Google Scholar 

  2. Folpe A. Neoplasms with perivascular epithelioid cell differentiation (PEComas). Lyon: IARC Press; 2002.

    Google Scholar 

  3. Petrolla AA, Xin W. Hepatic angiomyolipoma. Arch Pathol Lab Med. 2008;132(10):1679–82.

    PubMed  Google Scholar 

  4. Ishak K. Mesenchymal tumors of the liver. New York: Wiley; 1976.

    Google Scholar 

  5. Jiang TA, Zhao QY, Chen MY, Wang LJ, Ao JY. Diagnostic analysis of hepatic angiomyolipoma. Hepatobiliary Pancreat Dis Int. 2005;4(1):152–5.

    PubMed  Google Scholar 

  6. Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23(1):34–48.

    CAS  PubMed  Google Scholar 

  7. Terris B, Flejou JF, Picot R, Belghiti J, Henin D. Hepatic angiomyolipoma. A report of four cases with immunohistochemical and DNA-flow cytometric studies. Arch Pathol Lab Med. 1996;120(1):68–72.

    CAS  PubMed  Google Scholar 

  8. Ren N, Qin LX, Tang ZY, Wu ZQ, Fan J. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. World J Gastroenterol. 2003;9(8):1856–8.

    PubMed  PubMed Central  Google Scholar 

  9. Nonomura A, Enomoto Y, Takeda M, Tamura T, Kasai T, Yosikawa T, et al. Invasive growth of hepatic angiomyolipoma; a hitherto unreported ominous histological feature. Histopathology. 2006;48(7):831–5.

    CAS  PubMed  Google Scholar 

  10. Wang SN, Tsai KB, Lee KT. Hepatic angiomyolipoma with trace amounts of fat: a case report and literature review. J Clin Pathol. 2006;59(11):1196–9.

    PubMed  PubMed Central  Google Scholar 

  11. Xu AM, Zhang SH, Zheng JM, Zheng WQ, Wu MC. Pathological and molecular analysis of sporadic hepatic angiomyolipoma. Hum Pathol. 2006;37(6):735–41.

    CAS  PubMed  Google Scholar 

  12. Prasad SR, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics. 2005;25(2):321–31.

    PubMed  Google Scholar 

  13. Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68(1):64–80.

    CAS  PubMed  Google Scholar 

  14. Black ME, Hedgire SS, Camposano S, Paul E, Harisinghani M, Thiele EA. Hepatic manifestations of tuberous sclerosis complex: a genotypic and phenotypic analysis. Clin Genet. 2012;82(6):552–7.

    CAS  PubMed  Google Scholar 

  15. Cha I, Cartwright D, Guis M, Miller TR, Ferrell LD. Angiomyolipoma of the liver in fine-needle aspiration biopsies: its distinction from hepatocellular carcinoma. Cancer. 1999;87(1):25–30.

    CAS  PubMed  Google Scholar 

  16. Cai PQ, Wu YP, Xie CM, Zhang WD, Han R, Wu PH. Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison. Abdom Imaging. 2013;38(3):482–9.

    PubMed  Google Scholar 

  17. Wang Z, Xu HX, Xie XY, Xie XH, Kuang M, Xu ZF, et al. Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound. Br J Radiol. 2010;83(989):411–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Musante F, Derchi LE, Zappasodi F, Bazzocchi M, Riviezzo GC, Banderali A, et al. Myelolipoma of the adrenal gland: sonographic and CT features. AJR Am J Roentgenol. 1988;151(5):961–4.

    CAS  PubMed  Google Scholar 

  19. Ahmadi T, Itai Y, Takahashi M, Onaya H, Kobayashi T, Tanaka YO, et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging. 1998;23(5):520–6.

    CAS  PubMed  Google Scholar 

  20. Yan F, Zeng M, Zhou K, Shi W, Zheng W, Da R, et al. Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT. Eur J Radiol. 2002;41(1):12–8.

    PubMed  Google Scholar 

  21. Nonomura A, Minato H, Kurumaya H. Angiomyolipoma predominantly composed of smooth muscle cells: problems in histological diagnosis. Histopathology. 1998;33(1):20–7.

    CAS  PubMed  Google Scholar 

  22. Dalle I, Sciot R, de Vos R, Aerts R, van Damme B, Desmet V, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology. 2000;36(5):443–50.

    CAS  PubMed  Google Scholar 

  23. Nguyen TT, Gorman B, Shields D, Goodman Z. Malignant hepatic angiomyolipoma: report of a case and review of literature. Am J Surg Pathol. 2008;32(5):793–8.

    PubMed  Google Scholar 

  24. Deng YF, Lin Q, Zhang SH, Ling YM, He JK, Chen XF. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis. Pathol Res Pract. 2008;204(12):911–8.

    PubMed  Google Scholar 

  25. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002;26(4):493–7.

    PubMed  Google Scholar 

  26. Yang CY, Ho MC, Jeng YM, Hu RH, Wu YM, Lee PH. Management of Hepatic Angiomyolipoma. J Gastrointest Surg. 2007;11(4):452–7.

    PubMed  PubMed Central  Google Scholar 

  27. Ata AA, Kamel IA. Primary reticulum cell sarcoma of the liver. A case report. J Egypt Med Assoc. 1965;48(7):514–21.

    CAS  PubMed  Google Scholar 

  28. Elsayes KM, Menias CO, Willatt JM, Pandya A, Wiggins M, Platt J. Primary hepatic lymphoma: imaging findings. J Med Imaging Radiat Oncol. 2009;53(4):373–9.

    CAS  PubMed  Google Scholar 

  29. Noronha V, Shafi NQ, Obando JA, Kummar S. Primary non-Hodgkin’s lymphoma of the liver. Crit Rev Oncol Hematol. 2005;53(3):199–207.

    PubMed  Google Scholar 

  30. Tomasian A, Sandrasegaran K, Elsayes KM, Shanbhogue A, Shaaban A, Menias CO. Hematologic malignancies of the liver: spectrum of disease. Radiographics. 2015;35(1):71–86.

    PubMed  Google Scholar 

  31. Lisker-Melman M, Pittaluga S, Pluda JM, Kleiner DE, Thompson P, Martin P, et al. Primary lymphoma of the liver in a patient with acquired immune deficiency syndrome and chronic hepatitis B. Am J Gastroenterol. 1989;84(11):1445–8.

    CAS  PubMed  Google Scholar 

  32. Mohan C, Alurkar SS, Sharma OP, Advani SH. Primary liver lymphoma: a diagnostic dilemma. AJR Am J Roentgenol. 1991;157(2):413.

    CAS  PubMed  Google Scholar 

  33. Mohamed M, Fernando R. Diagnostic and therapeutic quandaries in a patient with primary hepatic lymphoma and concurrent hepatitis C infection. Indian J Hematol Blood Transfus. 2014;30(Suppl 1):394–7.

    PubMed  PubMed Central  Google Scholar 

  34. Sekiguchi Y, Yoshikawa H, Shimada A, Imai H, Wakabayashi M, Sugimoto K, et al. Primary hepatic circumscribed Burkitt’s lymphoma that developed after acute hepatitis B: report of a case with a review of the literature. J Clin Exp Hematop. 2013;53(2):167–73.

    PubMed  Google Scholar 

  35. Somaglino C, Pramaggiore P, Polastri R. Primary hepatic lymphoma in a patient with chronic hepatitis B and C infection: diagnostic pitfalls and therapeutic challenge. Updat Surg. 2014;66(1):89–90.

    Google Scholar 

  36. Kikuma K, Watanabe J, Oshiro Y, Shimogama T, Honda Y, Okamura S, et al. Etiological factors in primary hepatic B-cell lymphoma. Virchows Arch. 2012;460(4):379–87.

    PubMed  PubMed Central  Google Scholar 

  37. Nakayama S, Yokote T, Kobayashi K, Hirata Y, Akioka T, Miyoshi T, et al. Primary hepatic MALT lymphoma associated with primary biliary cirrhosis. Leuk Res. 2010;34:e17–20.

    CAS  PubMed  Google Scholar 

  38. Sato S, Masuda T, Oikawa H, Satoh T, Suzuki Y, Takikawa Y, et al. Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol. 1999;94(6):1669–73.

    CAS  PubMed  Google Scholar 

  39. Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol. 2008;35(11):2159–64.

    CAS  PubMed  Google Scholar 

  40. Sutton E, Malatjalian D, Hayne OA, Hanly JG. Liver lymphoma in systemic lupus erythematosus. J Rheumatol. 1989;16(12):1584–8.

    CAS  PubMed  Google Scholar 

  41. Honda H, Franken EA Jr, Barloon TJ, Smith JL. Hepatic lymphoma in cyclosporine-treated transplant recipients: sonographic and CT findings. AJR Am J Roentgenol. 1989;152(3):501–3.

    CAS  PubMed  Google Scholar 

  42. Palazzo JP, Lundquist K, Mitchell D, Mittal KR, Hann HW, Munoz S, et al. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis. Am J Gastroenterol. 1993;88(1):102–4.

    CAS  PubMed  Google Scholar 

  43. Rostaing L, Suc B, Fourtanier G, Baron E, Lloveras JJ, Durand D. Liver B cell lymphoma after liver transplantation. Transplant Proc. 1995;27(2):1781–2.

    CAS  PubMed  Google Scholar 

  44. Caccamo D, Pervez NK, Marchevsky A. Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1986;110(6):553–5.

    CAS  PubMed  Google Scholar 

  45. Ugurluer G, Miller RC, Li Y, Thariat J, Ghadjar P, Schick U, et al. Primary hepatic lymphoma: a retrospective, multicenter rare cancer network study. Rare Tumors. 2016;8(3):6502.

    PubMed  PubMed Central  Google Scholar 

  46. Lei KI. Primary non-Hodgkin’s lymphoma of the liver. Leuk Lymphoma. 1998;29(3–4):293–9.

    CAS  PubMed  Google Scholar 

  47. Avlonitis VS, Linos D. Primary hepatic lymphoma: a review. Eur J Surg. 1999;165(8):725–9.

    CAS  PubMed  Google Scholar 

  48. Page RD, Romaguera JE, Osborne B, Medeiros LJ, Rodriguez J, North L, et al. Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer. 2001;92(8):2023–9.

    CAS  PubMed  Google Scholar 

  49. Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med. 1994;121(9):633–40.

    CAS  PubMed  Google Scholar 

  50. Maher MM, McDermott SR, Fenlon HM, Conroy D, O'Keane JC, Carney DN, et al. Imaging of primary non-Hodgkin’s lymphoma of the liver. Clin Radiol. 2001;56(4):295–301.

    CAS  PubMed  Google Scholar 

  51. Kelekis NL, Semelka RC, Siegelman ES, Ascher SM, Outwater EK, Woosley JT, et al. Focal hepatic lymphoma: magnetic resonance demonstration using current techniques including gadolinium enhancement. Magn Reson Imaging. 1997;15(6):625–36.

    CAS  PubMed  Google Scholar 

  52. Emile JF, Azoulay D, Gornet JM, Lopes G, Delvart V, Samuel D, et al. Primary non-Hodgkin’s lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses. Ann Oncol. 2001;12(7):1005–10.

    CAS  PubMed  Google Scholar 

  53. Gazelle GS, Lee MJ, Hahn PF, Goldberg MA, Rafaat N, Mueller PR. US, CT, and MRI of primary and secondary liver lymphoma. J Comput Assist Tomogr. 1994;18(3):412–5.

    CAS  PubMed  Google Scholar 

  54. Rajesh S, Bansal K, Sureka B, Patidar Y, Bihari C, Arora A. The imaging conundrum of hepatic lymphoma revisited. Insights Imaging. 2015;6(6):679–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Colagrande S, Calistri L, Grazzini G, Nardi C, Busoni S, Morana G, et al. MRI features of primary hepatic lymphoma. Abdom Radiol (NY). 2018;49:2277.

    Google Scholar 

  56. Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics. 1993;13(5):1047–62.

    CAS  PubMed  Google Scholar 

  57. Loddenkemper C, Longerich T, Hummel M, Ernestus K, Anagnostopoulos I, Dienes HP, et al. Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification. Virchows Arch. 2007;450(5):493–502.

    PubMed  PubMed Central  Google Scholar 

  58. Swadley MJ, Deliu M, Mosunjac MB, Gunthel CJ, Nguyen ML, Hanley KZ. Primary and secondary hepatic lymphomas diagnosed by image-guided fine-needle aspiration: a retrospective study of clinical and cytomorphologic findings. Am J Clin Pathol. 2014;141(1):119–27.

    PubMed  Google Scholar 

  59. Bronowicki JP, Bineau C, Feugier P, Hermine O, Brousse N, Oberti F, et al. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology. 2003;37(4):781–7.

    PubMed  Google Scholar 

  60. Scoazec JY, Degott C, Brousse N, Barge J, Molas G, Potet F, et al. Non-Hodgkin’s lymphoma presenting as a primary tumor of the liver: presentation, diagnosis and outcome in eight patients. Hepatology. 1991;13(5):870–5.

    CAS  PubMed  Google Scholar 

  61. Chowla A, Malhi-Chowla N, Chidambaram A, Surick B. Primary hepatic lymphoma in hepatitis C: case report and review of the literature. Am Surg. 1999;65(9):881–3.

    CAS  PubMed  Google Scholar 

  62. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235–42.

    CAS  PubMed  Google Scholar 

  63. Cho MY, Kim JM, Sohn JH, Kim MJ, Kim KM, Kim WH, et al. Current trends of the incidence and pathological diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: multicenter study. Cancer Res Treat. 2012;44(3):157–65.

    PubMed  PubMed Central  Google Scholar 

  64. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39(6):707–12.

    PubMed  Google Scholar 

  65. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13–27.

    PubMed  Google Scholar 

  66. Kloppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology. 2009;90(2):162–6.

    PubMed  Google Scholar 

  67. Rindi G, Arnold R, Bosman F. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman F, Carneiro F, Hruban R, Theise N, editors. WHO classification of tumors of the digestive system. Lyon: IARC; 2010.

    Google Scholar 

  68. Iwao M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit. 2001;7(4):746–50.

    CAS  PubMed  Google Scholar 

  69. Donadon M, Torzilli G, Palmisano A, Del Fabbro D, Panizzo V, Maggioni M, et al. Liver resection for primary hepatic neuroendocrine tumours: report of three cases and review of the literature. Eur J Surg Oncol. 2006;32(3):325–8.

    CAS  PubMed  Google Scholar 

  70. Huang YQ, Xu F, Yang JM, Huang B. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases. Hepatobiliary Pancreat Dis Int. 2010;9(1):44–8.

    CAS  PubMed  Google Scholar 

  71. Park CH, Chung JW, Jang SJ, Chung MJ, Bang S, Park SW, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas. J Gastroenterol Hepatol. 2012;27(8):1306–11.

    PubMed  Google Scholar 

  72. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72.

    PubMed  Google Scholar 

  73. Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol. 2004;43(7):617–25.

    PubMed  Google Scholar 

  74. Yang K, Cheng YS, Yang JJ, Jiang X, Guo JX. Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations. Cancer Imaging. 2017;17(1):20.

    PubMed  PubMed Central  Google Scholar 

  75. Sippel RS, Chen H. Carcinoid tumors. Surg Oncol Clin N Am. 2006;15(3):463–78.

    PubMed  Google Scholar 

  76. Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, et al. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol. 2007;25(15):1967–73.

    CAS  PubMed  Google Scholar 

  77. Wang LX, Liu K, Lin GW, Jiang T. Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology. Cancer Imaging. 2015;15:13.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Critchley M. Octreotide scanning for carcinoid tumours. Postgrad Med J. 1997;73(861):399–402.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003;10(10):1171–5.

    PubMed  Google Scholar 

  80. Yang J, Kan Y, Ge BH, Yuan L, Li C, Zhao W. Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis. Acta Radiol. 2014;55(4):389–98.

    PubMed  Google Scholar 

  81. Fenwick SW, Wyatt JI, Toogood GJ, Lodge JP. Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg. 2004;239(2):210–9.

    PubMed  PubMed Central  Google Scholar 

  82. de Liguori CN, Manzia TM, Tariciotti L, Berlanda M, Orlando G, Tisone G. Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. Transplant Proc. 2009;41(4):1386–9.

    Google Scholar 

  83. Kress O, Wagner HJ, Wied M, Klose KJ, Arnold R, Alfke H. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors--a retrospective single-center analysis. Digestion. 2003;68(2–3):94–101.

    CAS  PubMed  Google Scholar 

  84. Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001;130(4):677–82; discussion 82-5.

    CAS  PubMed  Google Scholar 

  85. Gamblin TC, Christians K, Pappas SG. Radiofrequency ablation of neuroendocrine hepatic metastasis. Surg Oncol Clin N Am. 2011;20(2):273–9, vii-viii.

    PubMed  Google Scholar 

  86. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 1986;315(11):663–6.

    CAS  PubMed  Google Scholar 

  87. Das T, Banerjee S. Theranostic applications of Lutetium-177 in radionuclide therapy. Curr Radiopharm. 2016;9(1):94–101.

    CAS  PubMed  Google Scholar 

  88. Kam BL, Teunissen JJ, Krenning EP, de Herder WW, Khan S, van Vliet EI, et al. Lutetium-labelled peptides for therapy of neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012;39(Suppl 1):S103–12.

    PubMed  Google Scholar 

  89. Claringbold PG, Turner JH. NeuroEndocrine tumor therapy with Lutetium-177-octreotate and Everolimus (NETTLE): a phase I study. Cancer Biother Radiopharm. 2015;30(6):261–9.

    CAS  PubMed  Google Scholar 

  90. Gerald WL, Rosai J. Case 2. Desmoplastic small cell tumor with divergent differentiation. Pediatr Pathol. 1989;9(2):177–83.

    CAS  PubMed  Google Scholar 

  91. Gerald WL, Ladanyi M, de Alava E, Cuatrecasas M, Kushner BH, LaQuaglia MP, et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 1998;16(9):3028–36.

    CAS  PubMed  Google Scholar 

  92. Kushner BH, LaQuaglia MP, Wollner N, Meyers PA, Lindsley KL, Ghavimi F, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol. 1996;14(5):1526–31.

    CAS  PubMed  Google Scholar 

  93. Quaglia MP, Brennan MF. The clinical approach to desmoplastic small round cell tumor. Surg Oncol. 2000;9(2):77–81.

    CAS  PubMed  Google Scholar 

  94. Dufresne A, Cassier P, Couraud L, Marec-Berard P, Meeus P, Alberti L, et al. Desmoplastic small round cell tumor: current management and recent findings. Sarcoma. 2012;2012:714986.

    PubMed  PubMed Central  Google Scholar 

  95. Thomas R, Rajeswaran G, Thway K, Benson C, Shahabuddin K, Moskovic E. Desmoplastic small round cell tumour: the radiological, pathological and clinical features. Insights Imaging. 2013;4(1):111–8.

    PubMed  PubMed Central  Google Scholar 

  96. Bellah R, Suzuki-Bordalo L, Brecher E, Ginsberg JP, Maris J, Pawel BR. Desmoplastic small round cell tumor in the abdomen and pelvis: report of CT findings in 11 affected children and young adults. AJR Am J Roentgenol. 2005;184(6):1910–4.

    PubMed  Google Scholar 

  97. Kis B, O'Regan KN, Agoston A, Javery O, Jagannathan J, Ramaiya NH. Imaging of desmoplastic small round cell tumour in adults. Br J Radiol. 2012;85(1010):187–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Pickhardt PJ, Fisher AJ, Balfe DM, Dehner LP, Huettner PC. Desmoplastic small round cell tumor of the abdomen: radiologic-histopathologic correlation. Radiology. 1999;210(3):633–8.

    CAS  PubMed  Google Scholar 

  99. Ordonez NG. Desmoplastic small round cell tumor: I: a histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol. 1998;22(11):1303–13.

    CAS  PubMed  Google Scholar 

  100. Gerald WL, Rosai J, Ladanyi M. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci U S A. 1995;92(4):1028–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  101. Wong HH, Hatcher HM, Benson C, Al-Muderis O, Horan G, Fisher C, et al. Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature. Clin Sarcoma Res. 2013;3(1):14.

    PubMed  PubMed Central  Google Scholar 

  102. Howlader N. Surveillance epidemiology and end results (SEER) cancer statistics review, 1975–2008. Bethesda: National Cancer Institute; 2011.

    Google Scholar 

  103. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer. 2008;112(2):416–32.

    PubMed  Google Scholar 

  104. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. 1999.

    Google Scholar 

  105. Giardiello FM, Offerhaus GJ, Krush AJ, Booker SV, Tersmette AC, Mulder JW, et al. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr. 1991;119(5):766–8.

    CAS  PubMed  Google Scholar 

  106. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry. J Pediatr. 1998;132(3 Pt 1):398–400.

    CAS  PubMed  Google Scholar 

  107. Kitanovski L, Ovcak Z, Jazbec J. Multifocal hepatoblastoma in a 6-month-old girl with trisomy 18: a case report. J Med Case Rep. 2009;3:8319.

    PubMed  PubMed Central  Google Scholar 

  108. Hiyama E. Pediatric hepatoblastoma: diagnosis and treatment. Transl Pediatr. 2014;3(4):293–9.

    PubMed  PubMed Central  Google Scholar 

  109. De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer. 2008;44(4):545–50.

    PubMed  Google Scholar 

  110. Adeyiga AO, Lee EY, Eisenberg RL. Focal hepatic masses in pediatric patients. AJR Am J Roentgenol. 2012;199(4):W422–40.

    PubMed  Google Scholar 

  111. Dachman AH, Pakter RL, Ros PR, Fishman EK, Goodman ZD, Lichtenstein JE. Hepatoblastoma: radiologic-pathologic correlation in 50 cases. Radiology. 1987;164(1):15–9.

    CAS  PubMed  Google Scholar 

  112. Gubernick JA, Rosenberg HK, Ilaslan H, Kessler A. US approach to jaundice in infants and children. Radiographics. 2000;20(1):173–95.

    CAS  PubMed  Google Scholar 

  113. King SJ, Babyn PS, Greenberg ML, Phillips MJ, Filler RM. Value of CT in determining the resectability of hepatoblastoma before and after chemotherapy. AJR Am J Roentgenol. 1993;160(4):793–8.

    CAS  PubMed  Google Scholar 

  114. Lopez-Terrada D, Alaggio R, de Davila MT, Czauderna P, Hiyama E, Katzenstein H, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014;27(3):472–91.

    PubMed  Google Scholar 

  115. Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville de Goyet J, Gauthier F, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37(2):123–32; quiz 249-50.

    PubMed  Google Scholar 

  116. Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, et al. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015;102(1):108–13.

    CAS  PubMed  Google Scholar 

  117. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000;18(14):2665–75.

    CAS  PubMed  Google Scholar 

  118. Stocker JT, Ishak KG. Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Pediatr Pathol. 1983;1(3):245–67.

    CAS  PubMed  Google Scholar 

  119. Isaacs H Jr. Fetal and neonatal hepatic tumors. J Pediatr Surg. 2007;42(11):1797–803.

    PubMed  Google Scholar 

  120. Stanley P, Hall TR, Woolley MM, Diament MJ, Gilsanz V, Miller JH. Mesenchymal hamartomas of the liver in childhood: sonographic and CT findings. AJR Am J Roentgenol. 1986;147(5):1035–9.

    CAS  PubMed  Google Scholar 

  121. Kim SH, Kim WS, Cheon JE, Yoon HK, Kang GH, Kim IO, et al. Radiological spectrum of hepatic mesenchymal hamartoma in children. Korean J Radiol. 2007;8(6):498–505.

    PubMed  PubMed Central  Google Scholar 

  122. Thampy R, Elsayes KM, Menias CO, Pickhardt PJ, Kang HC, Deshmukh SP, et al. Imaging features of rare mesenychmal liver tumours: beyond haemangiomas. Br J Radiol. 2017;90(1079):20170373.

    PubMed  PubMed Central  Google Scholar 

  123. Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK. CT and MR imaging of benign hepatic and biliary tumors. Radiographics. 1999;19(2):431–51.

    CAS  PubMed  Google Scholar 

  124. Roberts EA, Liu P, Stringer D, Superina RA, Mancer K. Mesenchymal hamartoma in a 10-month-old infant: appearance by magnetic resonance imaging. Can Assoc Radiol J. 1989;40(4):219–21.

    CAS  PubMed  Google Scholar 

  125. Ito H, Kishikawa T, Toda T, Arai M, Muro H. Hepatic mensenchymal hamartoma of an infant. J Pediatr Surg. 1984;19(3):315–7.

    CAS  PubMed  Google Scholar 

  126. Stocker JT, Ishak KG. Undifferentiated (embryonal) sarcoma of the liver: report of 31 cases. Cancer. 1978;42(1):336–48.

    CAS  PubMed  Google Scholar 

  127. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol. 1983;14(6):512–37.

    CAS  PubMed  Google Scholar 

  128. Lenze F, Birkfellner T, Lenz P, Hussein K, Langer F, Kreipe H, et al. Undifferentiated embryonal sarcoma of the liver in adults. Cancer. 2008;112(10):2274–82.

    PubMed  Google Scholar 

  129. Nishio J, Iwasaki H, Sakashita N, Haraoka S, Isayama T, Naito M, et al. Undifferentiated (embryonal) sarcoma of the liver in middle-aged adults: smooth muscle differentiation determined by immunohistochemistry and electron microscopy. Hum Pathol. 2003;34(3):246–52.

    PubMed  Google Scholar 

  130. Bisogno G, Pilz T, Perilongo G, Ferrari A, Harms D, Ninfo V, et al. Undifferentiated sarcoma of the liver in childhood: a curable disease. Cancer. 2002;94(1):252–7.

    PubMed  Google Scholar 

  131. Pachera S, Nishio H, Takahashi Y, Yokoyama Y, Oda K, Ebata T, et al. Undifferentiated embryonal sarcoma of the liver: case report and literature survey. J Hepato-Biliary-Pancreat Surg. 2008;15(5):536–44.

    Google Scholar 

  132. Wei ZG, Tang LF, Chen ZM, Tang HF, Li MJ. Childhood undifferentiated embryonal liver sarcoma: clinical features and immunohistochemistry analysis. J Pediatr Surg. 2008;43(10):1912–9.

    PubMed  Google Scholar 

  133. Almogy G, Lieberman S, Gips M, Pappo O, Edden Y, Jurim O, et al. Clinical outcomes of surgical resections for primary liver sarcoma in adults: results from a single centre. Eur J Surg Oncol. 2004;30(4):421–7.

    PubMed  Google Scholar 

  134. Ros PR, Olmsted WW, Dachman AH, Goodman ZD, Ishak KG, Hartman DS. Undifferentiated (embryonal) sarcoma of the liver: radiologic-pathologic correlation. Radiology. 1986;161(1):141–5.

    CAS  PubMed  Google Scholar 

  135. Buetow PC, Buck JL, Pantongrag-Brown L, Marshall WH, Ros PR, Levine MS, et al. Undifferentiated (embryonal) sarcoma of the liver: pathologic basis of imaging findings in 28 cases. Radiology. 1997;203(3):779–83.

    CAS  PubMed  Google Scholar 

  136. Psatha EA, Semelka RC, Fordham L, Firat Z, Woosley JT. Undifferentiated (embryonal) sarcoma of the liver (USL): MRI findings including dynamic gadolinium enhancement. Magn Reson Imaging. 2004;22(6):897–900.

    PubMed  Google Scholar 

  137. Leuschner I, Schmidt D, Harms D. Undifferentiated sarcoma of the liver in childhood: morphology, flow cytometry, and literature review. Hum Pathol. 1990;21(1):68–76.

    CAS  PubMed  Google Scholar 

  138. May LT, Wang M, Albano E, Garrington T, Dishop M, Macy ME. Undifferentiated sarcoma of the liver: a single institution experience using a uniform treatment approach. J Pediatr Hematol Oncol. 2012;34(3):e114–6.

    PubMed  PubMed Central  Google Scholar 

  139. Plant AS, Busuttil RW, Rana A, Nelson SD, Auerbach M, Federman NC. A single-institution retrospective cases series of childhood undifferentiated embryonal liver sarcoma (UELS): success of combined therapy and the use of orthotopic liver transplant. J Pediatr Hematol Oncol. 2013;35(6):451–5.

    PubMed  Google Scholar 

  140. Weitz J, Klimstra DS, Cymes K, Jarnagin WR, D'Angelica M, La Quaglia MP, et al. Management of primary liver sarcomas. Cancer. 2007;109(7):1391–6.

    PubMed  Google Scholar 

  141. Asch MJ, Cohen AH, Moore TC. Hepatic and splenic lymphangiomatosis with skeletal involvement: report of a case and review of the literature. Surgery. 1974;76(2):334–9.

    CAS  PubMed  Google Scholar 

  142. Enzinger F, Weiss S. Soft tissue tumour. 3rd ed. St Louis: Mosby; 1998.

    Google Scholar 

  143. Losanoff JE, Richman BW, El-Sherif A, Rider KD, Jones JW. Mesenteric cystic lymphangioma. J Am Coll Surg. 2003;196(4):598–603.

    PubMed  Google Scholar 

  144. Stavropoulos M, Vagianos C, Scopa CD, Dragotis C, Androulakis J. Solitary hepatic lymphangioma. A rare benign tumour: a case report. HPB Surg. 1994;8(1):33–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  145. Koh CC, Sheu JC. Hepatic lymphangioma--a case report. Pediatr Surg Int. 2000;16(7):515–6.

    CAS  PubMed  Google Scholar 

  146. O'Sullivan DA, Torres VE, de Groen PC, Batts KP, King BF, Vockley J. Hepatic lymphangiomatosis mimicking polycystic liver disease. Mayo Clin Proc. 1998;73(12):1188–92.

    CAS  PubMed  Google Scholar 

  147. Allen JG, Riall TS, Cameron JL, Askin FB, Hruban RH, Campbell KA. Abdominal lymphangiomas in adults. J Gastrointest Surg. 2006;10(5):746–51.

    PubMed  Google Scholar 

  148. Matsumoto T, Ojima H, Akishima-Fukasawa Y, Hiraoka N, Onaya H, Shimada K, et al. Solitary hepatic lymphangioma: report of a case. Surg Today. 2010;40(9):883–9.

    PubMed  Google Scholar 

  149. Liu Q, Sui CJ, Li BS, Gao A, Lu JY, Yang JM. Solitary hepatic lymphangioma: a one-case report. Springerplus. 2014;3:314.

    PubMed  PubMed Central  Google Scholar 

  150. Biondi A, Malaguarnera G, Vacante M, Berretta M, D'Agata V, Malaguarnera M, et al. Elevated serum levels of Chromogranin A in hepatocellular carcinoma. BMC Surg. 2012;12(Suppl 1):S7.

    PubMed  PubMed Central  Google Scholar 

  151. Choi WJ, Jeong WK, Kim Y, Kim J, Pyo JY, Oh YH. MR imaging of hepatic lymphangioma. Korean J Hepatol. 2012;18(1):101–4.

    PubMed  PubMed Central  Google Scholar 

  152. Levy AD, Cantisani V, Miettinen M. Abdominal lymphangiomas: imaging features with pathologic correlation. AJR Am J Roentgenol. 2004;182(6):1485–91.

    PubMed  Google Scholar 

  153. Siegel MJ, Glazer HS, St Amour TE, Rosenthal DD. Lymphangiomas in children: MR imaging. Radiology. 1989;170(2):467–70.

    CAS  PubMed  Google Scholar 

  154. Roisman I, Manny J, Fields S, Shiloni E. Intra-abdominal lymphangioma. Br J Surg. 1989;76(5):485–9.

    CAS  PubMed  Google Scholar 

  155. Stein M, Hsu RK, Schneider PD, Ruebner BH, Mina Y. Alcohol ablation of a mesenteric lymphangioma. J Vasc Interv Radiol. 2000;11(2 Pt 1):247–50.

    CAS  PubMed  Google Scholar 

  156. De Santis M, Calo GF, Trombini P, Romagnoli R. Percutaneous sclerosing treatment with ethanol of a large cystic lymphangioma of the neck in an adult. Radiol Med. 2003;105(1–2):127–30.

    PubMed  Google Scholar 

  157. Banieghbal B, Davies MR. Guidelines for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg. 2003;13(2):103–7.

    CAS  PubMed  Google Scholar 

  158. Ramchand S, Ahmed Y, Baskerville L. Lipoma of the liver. Arch Pathol. 1970;90(4):331–3.

    CAS  PubMed  Google Scholar 

  159. Marti-Bonmati L, Menor F, Vizcaino I, Vilar J. Lipoma of the liver: US, CT, and MRI appearance. Gastrointest Radiol. 1989;14(2):155–7.

    CAS  PubMed  Google Scholar 

  160. Roberts JL, Fishman EK, Hartman DS, Sanders R, Goodman Z, Siegelman SS. Lipomatous tumors of the liver: evaluation with CT and US. Radiology. 1986;158(3):613–7.

    CAS  PubMed  Google Scholar 

  161. Reading CC, Charboneau JW. Case of the day. Ultrasound. Hepatic lipoma. Radiographics. 1990;10(3):511–2.

    CAS  PubMed  Google Scholar 

  162. Puljiz Z, Petricevic M, Bratanic A, Barisic I, Puljiz M, Karin Z. An unusually large liver lipoma. Med Glas (Zenica). 2012;9(2):411–4.

    Google Scholar 

  163. Bruneton JN, Kerboul P, Drouillard J, Menu Y, Normand F, Santini N. Hepatic lipomas: ultrasound and computed tomographic findings. Gastrointest Radiol. 1987;12(4):299–303.

    CAS  PubMed  Google Scholar 

  164. Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, et al. Fat in the liver: diagnosis and characterization. Eur Radiol. 2006;16(10):2292–308.

    PubMed  Google Scholar 

  165. Dalal KM, Antonescu CR, Singer S. Diagnosis and management of lipomatous tumors. J Surg Oncol. 2008;97(4):298–313.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Mayo Clinic, Rochester, MN, USA

    Patrick J. Navin & Sudhakar K. Venkatesh

  2. Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

    Ju Dong Yang

  3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

    Michael S. Torbenson

Authors
  1. Patrick J. Navin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ju Dong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael S. Torbenson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sudhakar K. Venkatesh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sudhakar K. Venkatesh .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

    Lewis R. Roberts

  2. Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Ju Dong Yang

  3. Department of Radiology, Mayo Clinic, Rochester, MN, USA

    Sudhakar K. Venkatesh

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Navin, P.J., Yang, J.D., Torbenson, M.S., Venkatesh, S.K. (2020). Rare Liver Tumors. In: Roberts, L., Yang, J., Venkatesh, S. (eds) Evaluation and Management of Liver Masses. Springer, Cham. https://doi.org/10.1007/978-3-030-46699-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-46699-2_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-46698-5

  • Online ISBN: 978-3-030-46699-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation